🇺🇸🇨🇳⚡️ — In 2024, Chinas National Medical Products Administration (NMPA) approved 83 new drugs, while the US FDA approved 50.

Chinas share of new commercial clinical trials grew from 8% of the global total in 2013 to 30% in 2024, second only to the US with 35%.

Last year, the Chinese company Jiangsu Hengrui Pharmaceuticals overtook AstraZeneca to become the worlds largest sponsor of clinical trials.

@IntelSlava

🇪🇺🇺🇸✡️ EU regulators green light the Paramount Skydance $110bn acquisition of Warner Bros, after Paramount has agreed to end a distribution partnership with Universal Pictures Europe.

US regulators still have to give the go ahead for the super-merger to finalise, however.

✍️ This goes to show how this isn’t really about increasing revenue. The Ellisons (who own Paramount-Skydance and are extremely Zionist) have sacrificed a huge chunk of their sales in Europe to get the EU’s approval of the merger.

What they’re really after is influence and vertical integration in the media sphere, where they will pursue a takeover in the narrative and try to reconquer the space in favour of Israel’s public image.